Hastings Paul J
- SEC CIK
- 0001309702
In the past year, 2 open-market sale filings worth $58.7K and no purchases.
Current role at each company
- NKTX Nkarta, Inc.Chief Executive Officeras of Jun 22, 2026
- ENGN enGene Therapeutics Inc.Directoras of Jun 17, 2026
- PCRX Pacira BioSciences, Inc.Directoras of Jun 13, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $58.7K
- 2 filings
- Net
- −$58.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hastings Paul J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NKTX Nkarta, Inc.
Chief Executive Officer11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 (view filing) | Jun 18 | 4 days | Hastings Paul JChief Executive Officer | SSale | −1.78K | $2.71 | −$4.81K | −0.5%390.2K after | |
| Jan 20, 2026 (view filing) | Jan 15 | 5 days | Hastings Paul JChief Executive Officer | SSale | −26.0K | $2.07 | −$53.9K | −6.3%390.0K after | |
| Jun 20, 2025 (view filing) | Jun 18 | 2 days | Hastings Paul JChief Executive Officer | SSale | −1.79K | $1.79 | −$3.20K | −0.6%320.1K after | |
| Jan 17, 2025 (view filing) | Jan 15 | 2 days | Hastings Paul JChief Executive Officer | SSale | −17.4K | $2.20 | −$38.2K | −5.2%319.9K after | |
| Jun 20, 2024 (view filing) | Jun 18 | 2 days | Hastings Paul JChief Executive Officer | SSale | −1.77K | $5.60 | −$9.91K | −0.7%240.7K after | |
| Jan 18, 2024 (view filing) | Jan 16 | 2 days | Hastings Paul JChief Executive Officer | SSale | −9.70K | $8.74 | −$84.8K | −2.4%390.5K after | |
| Jun 22, 2023 (view filing) | Jun 20 | 2 days | Hastings Paul JChief Executive Officer | SSale | −1.70K | $4.85 | −$8.26K | −0.5%313.4K after | |
| Jan 18, 2023 (view filing) | Jan 17 | 1 day | Hastings Paul JChief Executive Officer | SSale | −3.69K | $5.49 | −$20.3K | −1.2%313.1K after | |
| Sep 30, 2022 (view filing) | Sep 28-29 | 2 days | Hastings Paul JChief Executive Officer | SSale | −23.9K | $13.03 | −$311.1K | −8.7%250.5K after | 2 lots |
| Sep 22, 2022 (view filing) | Sep 21 | 1 day | Hastings Paul JChief Executive Officer | SSale | −6.13K | $13.01 | −$79.7K | −2.2%274.3K after |
PCRX Pacira BioSciences, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2024 (view filing) | Jun 13 | Same day | Hastings Paul JDirector | SSale | −880 | $28.38 | −$25.0K | −6.5%12.7K after | 10b5-1 |
| Jun 7, 2023 (view filing) | Jun 5 | 2 days | Hastings Paul JDirector | SSale | −580 | $38.34 | −$22.2K | −8.1%6.60K after | |
| May 17, 2023 (view filing) | May 15 | 2 days | Hastings Paul JDirector | SSale | −7.00K | $41.85 | −$292.9K | −49.4%7.18K after | 10b5-1 |
| Jul 13, 2022 (view filing) | Jul 11 | 2 days | Hastings Paul JDirector | SSale | −533 | $56.95 | −$30.4K | −6.9%7.18K after |